相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sensitive and simultaneous quantitation of 6 beta-hydroxycortisol and cortisol in human plasma by LC-MS/MS coupled with stable isotope dilution method
Ryohei Hirano et al.
JOURNAL OF MASS SPECTROMETRY (2018)
A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects
Pierre-Eric Juif et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Distribution of Exogenous and Endogenous CYP3A Markers and Related Factors in Healthy Males and Females
Jieon Lee et al.
AAPS JOURNAL (2017)
Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects
Sarah J. Woolsey et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2016)
Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese
S. W. Chan et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2016)
Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans
Nicolas Hohmann et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Role of Human Albumin in the Management of Complications of Liver Cirrhosis
Mauro Bernardi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2014)
Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance
K-H Shin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Intraindividual and Interindividual Variabilities in Endogenous Cortisol 6β-Hydroxylation Clearance as an Index for In Vivo CYP3A Phenotyping in Humans
Hiromi Shibasaki et al.
DRUG METABOLISM AND DISPOSITION (2013)
Evaluation of 6β-Hydroxycortisol, 6β-Hydroxycortisone, and a Combination of the Two as Endogenous Probes for Inhibition of CYP3A4 In Vivo
C-C Peng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
A simple liquid chromatography-tandem mass spectrometry method for urinary free cortisol analysis: suitable for routine purpose
Silvia Persichilli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2010)
Quantification of cortisol and 6 beta-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity
Ursula Lutz et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism
Xi Luo et al.
ACTA PHARMACOLOGICA SINICA (2009)
Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
Seongwook Jeong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Drugs as CYP3A probes, inducers, and inhibitors
Yi-Tong Liu et al.
DRUG METABOLISM REVIEWS (2007)
The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity
Daniel Kurnik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Simultaneous determination of 6β-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity
ZY Hu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Interindividual and intraindividual variability of the urinary 6β-hydroxycortisol/cortisol ratio in Chinese subjects implications of its use fair evaluating CYP3A activity
OQR Yin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans
T Furuta et al.
DRUG METABOLISM AND DISPOSITION (2003)
Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2002)
Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes
DS Streetman et al.
PHARMACOGENETICS (2000)
Specific determination of urinary 6 beta-hydroxycortisol and cortisol by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry
M Ohno et al.
JOURNAL OF CHROMATOGRAPHY B (2000)